查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1797754

药品阻隔包装材料市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Barrier Packaging Materials for Pharmaceuticals Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 192 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球药品阻隔包装材料市场价值为 284 亿美元，预计到 2034 年将以 6.4% 的复合年增长率成长，达到 525 亿美元。 2024 年全球药品阻隔包装材料市场价值为 284 亿美元，预计到 2034 年将以 6.4% 的复合年增长率成长，达到 525 亿美元。对保护药品免受湿气、氧气、光线和微生物污染的包装的需求不断增长，推动了高阻隔材料的应用。这些解决方案对于维持现代药物製剂的化学稳定性和治疗价值至关重要。随着生物製剂、个人化医疗和复杂药物成分的兴起，包装要求变得更加严格，促使製造商投资于提供卓越保护的先进材料。多层层压板、PVDC 涂层和铝基薄膜等阻隔技术因其与多种剂型相容且符合全球监管标准而获得广泛认可。

医药市场阻隔包装材料 - IMG1

製造商越来越重视开发可回收、无溶剂的阻隔材料，以满足永续发展需求和不断发展的医药需求。精准治疗的趋势增加了对耐热性和防潮性更强的新型材料的需求。为了应对这些挑战，製造商正在探索包括奈米涂层和混合结构在内的包装创新技术，以延长保质期并确保产品在全球分销过程中的完整性。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 284亿美元
预测值 525亿美元
复合年增长率 6.4%

2024年，铝箔阻隔材料市场规模达117亿美元，凭藉其在保护吸湿性药物、药片和胶囊等敏感产品方面的卓越性能，维持了强劲的市场地位。冷成型和带状包装箔尤其适用于对湿度敏感且稳定性至关重要的应用。

固体剂型市场在2024年创造了134亿美元的市场规模，预计到2034年将以5.9%的复合年增长率成长。这些产品主要为片剂和胶囊，需要具有强大阻隔性能的包装，以适应各种储存和运输环境。高性能薄膜和铝箔已成为确保产品寿命和维持疗效的标准。

2024年，美国医药阻隔包装材料市场规模达78亿美元，占82%的市占率。由于製药业的扩张、仿製药产量的提高以及先进药物输送技术的创新，美国市场将继续保持成长势头。随着对生物製剂、生物相似药和溶剂型活性成分等复杂製剂的保护需求不断增长，企业正在加速向更具弹性、响应速度更快的包装解决方案转型。

塑造全球医药阻隔包装材料市场的关键公司包括 Winpak Ltd.、Amcor plc、Sealed Air Corporation、Constantia flexibles 和 Berry Global Inc.。为了维持并扩大市场份额，医药阻隔包装领域的领先公司正在部署一系列策略方针。他们大力投资研发，以开发符合环境和药品监管标准的高阻隔、可回收和单一材料薄膜。与药厂建立策略伙伴关係，帮助他们跟上不断变化的配方需求。许多公司也透过采用自动化和智慧製造来提高生产能力，以确保一致性和可扩展性。透过併购和区域製造中心扩大全球影响力，这些公司能够满足新兴市场日益增长的需求。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
    • 供应商概况
    • 利润率
    • 每个阶段的增值
    • 影响价值链的因素
    • 中断
  • 产业衝击力
    • 成长动力
      • 提高药物稳定性的要求。
      • 生物製剂和特种药物的成长
      • 监理合规要求
    • 产业陷阱与挑战
      • 材料和加工成本高
      • 复杂的监管审批流程
      • 环境与永续发展压力
    • 市场机会
  • 成长潜力分析
  • 监管格局
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特的分析
  • PESTEL分析
  • 价格趋势
    • 按地区
  • 未来市场趋势
  • 技术和创新格局
    • 当前的技术趋势
    • 新兴技术
  • 专利格局
  • 贸易统计（HS编码）（註：仅提供重点国家的贸易统计资料）
    • 主要进口国
    • 主要出口国
  • 永续性和环境方面
    • 永续实践
    • 减少废弃物的策略
    • 生产中的能源效率
    • 环保倡议
  • 碳足迹考量

第四章：竞争格局

  • 介绍
  • 公司市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • MEA
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估计与预测：按材料类型，2021 - 2034 年

  • 主要趋势
  • 铝箔阻隔材料
    • 纯铝箔
      • 标准厚等级
      • 高性能合金
      • 特殊表面处理
    • 层压铝结构
      • 铝聚合物层压板
      • 铝纸复合材料
      • 多层铝系统
  • 聚合物薄膜阻隔材料
    • 涂层铝解决方案
      • 聚合物涂层铝
      • 功能涂层应用
      • 效能增强技术
    • PVDC（聚偏二氯乙烯）系统
      • 涂层应用
      • 薄膜配方
    • EVOH（乙烯乙烯醇）阻隔材料
      • 阻隔膜应用
      • 层压系统
    • PET（聚对苯二甲酸乙二醇酯）薄膜
      • 标准宠物围栏
      • 强化屏障宠物
      • 特殊配方
    • 其他聚合物屏障
      • PE（聚乙烯）系统
      • PP（聚丙烯）屏障
      • 特种聚合物解决方案
  • 多层阻隔系统
    • 层压结构
      • 黏合剂基底层压板
      • 挤压涂层系统
      • 热黏合结构
    • 共挤屏障
      • 多层共挤
      • 连接层技术
      • 效能最佳化
  • 先进的阻隔技术
    • 奈米科技增强屏障
    • 等离子沉积涂层
    • 原子层沉积系统

第六章：市场估计与预测：按应用，2021 - 2034 年

  • 主要趋势
  • 固体剂型
    • 片剂和囊片
      • 速释製剂
      • 缓释系统
      • 专业平板电脑应用
    • 胶囊
      • 硬明胶胶囊
      • 软胶囊
      • 肠溶胶囊
    • 粉末和颗粒
      • 散装粉末包装
      • 单剂量小袋
      • 重组产品
  • 液体剂型
    • 口服液
      • 糖浆和混悬液
      • 溶液和乳液
      • 儿科製剂
    • 注射溶液
      • 小瓶和安瓿瓶
      • 预充式註射器
      • 静脉输液袋和容器
    • 外用製剂
      • 乳膏和药膏
      • 凝胶和乳液
      • 透皮系统
  • 生物製剂和生物相似药
    • 蛋白质疗法
      • 单株抗体
      • 疫苗
      • 酵素疗法
    • 细胞和基因疗法
      • 活细胞产品
      • 基因治疗载体
      • 再生医学
  • 特种药品
    • 管制物质
    • 孤儿药
    • 个人化医疗
    • 临床试验材料

第七章：市场估计与预测：依包装形式，2021 - 2034 年

  • 主要趋势
  • 吸塑包装
    • 热成型泡罩
      • PVC泡罩系统
      • 聚氯乙烯涂层泡罩
      • 铝铝泡罩
    • 冷成型泡罩
      • 铝基系统
      • 高阻隔性能
      • 专业应用
    • 特殊泡罩形式
      • 儿童安全泡罩
      • 适合老年人的设计
      • 单位剂量系统
  • 软包装
    • 小袋和小袋
      • 单剂量袋装
      • 多剂量包装
      • 棒状包装
    • 袋子和包装
      • 散装包装解决方案
      • 保护性包装
      • 中间包装
  • 硬质包装
    • 瓶子和容器
      • 塑胶瓶系统
      • 玻璃容器应用
      • 增强屏障的封闭
    • 小瓶和安瓿瓶
      • 玻璃瓶系统
      • 塑胶瓶应用
      • 专用封盖
  • 特殊包装形式
    • 预充式註射器
    • 墨水匣系统
    • 吸入装置
    • 透皮贴剂

第八章：市场估计与预测：按地区，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第九章：公司简介

  • Amcor Plc
  • Constantia Flexibles Group GmbH
  • Klockner Pentaplast Group
  • Tekni-Plex, Inc
  • Uflex Limited
  • Mondi Group
  • Sealed Air Corporation
  • Winpak Ltd
  • Huhtamaki Oyj
  • Berry Global Inc
  • CCL Industries Inc
  • Schott AG
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc
  • Sonoco Products Company
简介目录
Product Code: 14523

The Global Barrier Packaging Materials for Pharmaceuticals Market was valued at USD 28.4 billion in 2024 and is estimated to grow at a CAGR of 6.4% to reach USD 52.5 billion by 2034. The Global Barrier Packaging Materials for Pharmaceuticals Market was valued at USD 28.4 billion in 2024 and is estimated to grow at a CAGR of 6.4% to reach USD 52.5 billion by 2034. The increasing demand for packaging that protects pharmaceutical products from moisture, oxygen, light, and microbial contamination is driving the adoption of high-barrier materials. These solutions are essential for preserving the chemical stability and therapeutic value of modern drug formulations. With the rise in biologics, personalized medicine, and complex drug compositions, packaging requirements have become more stringent, leading manufacturers to invest in advanced materials that offer superior protection. Barrier technologies such as multilayer laminates, PVDC coatings, and aluminum-based films have gained widespread acceptance due to their compatibility with a wide range of dosage forms and adherence to global regulatory standards.

Barrier Packaging Materials for Pharmaceuticals Market - IMG1

Manufacturers are placing growing emphasis on developing recyclable, solvent-free barrier materials that comply with sustainability mandates and evolving pharmaceutical requirements. The trend toward precision therapies has increased demand for novel materials with improved thermal resistance and moisture control. Packaging innovations, including nanocoatings and hybrid structures, are being explored to meet these challenges while extending shelf life and ensuring product integrity during global distribution.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$28.4 Billion
Forecast Value$52.5 Billion
CAGR6.4%

The aluminum foil barrier materials segment accounted for USD 11.7 billion in 2024, maintaining a strong foothold due to their exceptional performance in protecting sensitive products like hygroscopic drugs, tablets, and capsules. Cold-form and strip-pack foils are particularly preferred in moisture-sensitive applications where stability is critical.

The solid dosage segment generated USD 13.4 billion in 2024 and is expected to grow at a CAGR of 5.9% through 2034. These products, primarily tablets and capsules, require packaging with robust barrier properties to withstand diverse storage and transit environments. High-performance films and aluminum foils have become standard in ensuring product longevity and maintaining therapeutic efficacy.

U.S. Barrier Packaging Materials for Pharmaceuticals Market generated USD 7.8 billion in 2024, capturing 82% share. Growth in the country continues due to expanding pharmaceutical manufacturing, increased generic drug output, and innovation in advanced drug delivery technologies. As the demand rises for protecting complex formulations such as biologics, biosimilars, and solvent-based active ingredients, the shift to more resilient and responsive packaging solutions is accelerating.

Key companies shaping the Global Barrier Packaging Materials for Pharmaceuticals Market include Winpak Ltd., Amcor plc, Sealed Air Corporation, Constantia Flexibles, and Berry Global Inc. To maintain and grow their market presence, leading companies in the pharmaceutical barrier packaging sector are deploying a range of strategic approaches. They are heavily investing in R&D to develop high-barrier, recyclable, and mono-material films that meet both environmental and pharmaceutical regulatory standards. Strategic partnerships with drug manufacturers help them stay aligned with evolving formulation needs. Many firms are also enhancing production capabilities by adopting automation and smart manufacturing to ensure consistency and scalability. Expanding their global reach through mergers, acquisitions, and regional manufacturing hubs allows these players to address rising demand in emerging markets.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Material type
    • 2.2.3 Application
    • 2.2.4 Packaging format
  • 2.3 TAM ANALYSIS, 2025-2034
  • 2.4 CXO PERSPECTIVES: strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing drug stability requirements.
      • 3.2.1.2 Biologics and specialty drug growth
      • 3.2.1.3 Regulatory compliance mandates
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High material and processing costs
      • 3.2.2.2 Complex regulatory approval processes
      • 3.2.2.3 Environmental and sustainability pressures
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
    • 3.6.1 Technology and Innovation Landscape
    • 3.6.2 Current technological trends
    • 3.6.3 Emerging technologies
  • 3.7 Price trends
    • 3.7.1 By region
  • 3.8 Future market trends
  • 3.9 Technology and innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent landscape
  • 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint considerations

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Material Type, 2021 - 2034 (USD Billion) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 Aluminum foil barrier materials
    • 5.2.1 Pure aluminum foil
      • 5.2.1.1 Standard thickness grades
      • 5.2.1.2 High-performance alloys
      • 5.2.1.3 Specialized surface treatments
    • 5.2.2 Laminated aluminum structures
      • 5.2.2.1 Aluminum-polymer laminates
      • 5.2.2.2 Aluminum-paper composites
      • 5.2.2.3 Multi-layer aluminum systems
  • 5.3 Polymer film barrier materials
    • 5.3.1 Coated aluminum solutions
      • 5.3.1.1 Polymer-coated aluminum
      • 5.3.1.2 Functional coating applications
      • 5.3.1.3 Performance enhancement technologies
    • 5.3.2 PVDC (polyvinylidene chloride) systems
      • 5.3.2.1 Coating applications
      • 5.3.2.2 Film formulations
    • 5.3.3 EVOH (ethylene vinyl alcohol) barriers
      • 5.3.3.1 Barrier film applications
      • 5.3.3.2 Lamination systems
    • 5.3.4 PET (polyethylene terephthalate) films
      • 5.3.4.1 Standard pet barriers
      • 5.3.4.2 Enhanced barrier pet
      • 5.3.4.3 Specialty formulations
    • 5.3.5 Other polymer barriers
      • 5.3.5.1 PE (polyethylene) systems
      • 5.3.5.2 PP (polypropylene) barriers
      • 5.3.5.3 Specialty polymer solutions
  • 5.4 Multi-layer barrier systems
    • 5.4.1 Laminated structures
      • 5.4.1.1 Adhesive-based laminates
      • 5.4.1.2 Extrusion-coated systems
      • 5.4.1.3 Thermal bonded structures
    • 5.4.2 Coextruded barriers
      • 5.4.2.1 Multi-layer coextrusion
      • 5.4.2.2 Tie-layer technologies
      • 5.4.2.3 Performance optimization
  • 5.5 Advanced barrier technologies
    • 5.5.1 Nanotechnology-enhanced barriers
    • 5.5.2 Plasma-deposited coatings
    • 5.5.3 Atomic layer deposition systems

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 (USD Billion) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Solid dosage forms
    • 6.2.1 Tablets and caplets
      • 6.2.1.1 Immediate-release formulations
      • 6.2.1.2 Extended-release systems
      • 6.2.1.3 Specialty tablet applications
    • 6.2.2 Capsules
      • 6.2.2.1 Hard gelatin capsules
      • 6.2.2.2 Soft gelatin capsules
      • 6.2.2.3 Enteric-coated capsules
    • 6.2.3 Powders and granules
      • 6.2.3.1 Bulk powder packaging
      • 6.2.3.2 Unit-dose sachets
      • 6.2.3.3 Reconstitution products
  • 6.3 Liquid dosage forms
    • 6.3.1 Oral liquids
      • 6.3.1.1 Syrups and suspensions
      • 6.3.1.2 Solutions and emulsions
      • 6.3.1.3 Pediatric formulations
    • 6.3.2 Injectable solutions
      • 6.3.2.1 Vials and ampoules
      • 6.3.2.2 Prefilled syringes
      • 6.3.2.3 IV bags and containers
    • 6.3.3 Topical formulations
      • 6.3.3.1 Creams and ointments
      • 6.3.3.2 Gels and lotions
      • 6.3.3.3 Transdermal systems
  • 6.4 Biologics and biosimilars
    • 6.4.1 Protein therapeutics
      • 6.4.1.1 Monoclonal antibodies
      • 6.4.1.2 Vaccines
      • 6.4.1.3 Enzyme therapies
    • 6.4.2 Cell and gene therapies
      • 6.4.2.1 Living cell products
      • 6.4.2.2 Gene therapy vectors
      • 6.4.2.3 Regenerative medicine
  • 6.5 Specialty pharmaceuticals
    • 6.5.1 Controlled substances
    • 6.5.2 Orphan drugs
    • 6.5.3 Personalized medicine
    • 6.5.4 Clinical trial materials

Chapter 7 Market Estimates and Forecast, By Packaging Format, 2021 - 2034 (USD Billion) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 Blister packaging
    • 7.2.1 Thermoformed blisters
      • 7.2.1.1 Pvc-based blister systems
      • 7.2.1.2 Pvdc-coated blisters
      • 7.2.1.3 Aluminum-aluminum blisters
    • 7.2.2 Cold-formed blisters
      • 7.2.2.1 Aluminum-based systems
      • 7.2.2.2 High-barrier performance
      • 7.2.2.3 Specialty applications
    • 7.2.3 Specialty blister formats
      • 7.2.3.1 Child-resistant blisters
      • 7.2.3.2 Senior-friendly designs
      • 7.2.3.3 Unit-dose systems
  • 7.3 Flexible packaging
    • 7.3.1 Pouches and sachets
      • 7.3.1.1 Single-dose pouches
      • 7.3.1.2 Multi-dose packaging
      • 7.3.1.3 Stick packs
    • 7.3.2 Bags and wraps
      • 7.3.2.1 Bulk packaging solutions
      • 7.3.2.2 Protective wrapping
      • 7.3.2.3 Intermediate packaging
  • 7.4 Rigid packaging
    • 7.4.1 Bottles and containers
      • 7.4.1.1 Plastic bottle systems
      • 7.4.1.2 Glass container applications
      • 7.4.1.3 Barrier-enhanced closures
    • 7.4.2 Vials and ampoules
      • 7.4.2.1 Glass vial systems
      • 7.4.2.2 Plastic vial applications
      • 7.4.2.3 Specialized closures
  • 7.5 Specialized packaging formats
    • 7.5.1 Prefilled syringes
    • 7.5.2 Cartridge systems
    • 7.5.3 Inhalation devices
    • 7.5.4 Transdermal patches

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 (USD Billion) (Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Amcor Plc
  • 9.2 Constantia Flexibles Group GmbH
  • 9.3 Klockner Pentaplast Group
  • 9.4 Tekni-Plex, Inc
  • 9.5 Uflex Limited
  • 9.6 Mondi Group
  • 9.7 Sealed Air Corporation
  • 9.8 Winpak Ltd
  • 9.9 Huhtamaki Oyj
  • 9.10 Berry Global Inc
  • 9.11 CCL Industries Inc
  • 9.12 Schott AG
  • 9.13 Gerresheimer AG
  • 9.14 West Pharmaceutical Services, Inc
  • 9.15 Sonoco Products Company